Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Alex Azar speaks at an August 29 press conference. Photo: Tasos Katopodis/Getty Images

While praising "real progress" in the fight against growing antimicrobial resistance, HHS Secretary Alex Azar challenged individuals and private and public organizations around the world to renew efforts to end the "scourge of AMR" while speaking Monday at the UN General Assembly.

Why it matters: At least 23,000 Americans and 700,000 people globally die every year from AMR infections — but this number is believed to be on the low end. A recent UN report warned that AMR could kill up to 10 million people worldwide per year by 2050 if action isn't taken.

What's new: In the year since the U.S. government and its partners launched the AMR Challenge, there's been progress made, Azar said.

  • The CDC collected nearly 350 commitments from 33 countries to escalate efforts via government and private sector to lessen antibiotic resistance.
  • These commitments are from drug and health insurance companies, food animal producers and purchasers like McDonald's and Yum!, doctors and hospitals, government health officials, and other leaders from around the world.

Case in point: Azar noted the example of Premier, a large U.S. health care organization of 4,000 hospitals and 175,000 medical providers that "was able to lower the rate of a particular health-care associated infection [Clostridioides difficile] by 46% in 500 hospitals since 2015 — through coaching calls, site visits, webinars and a new website focused on AMR."

But, but, but: Azar and health officials from other countries emphasized that despite some progress, the problem continues to worsen as dozens of pathogens become resistant to treatments.

Meanwhile, a study out last week in Science developed a geospatial model using data from 901 point-prevalence surveys around the world between 2000 and 2018 examining rates of antibiotic resistance in animals and food products in E. coli, Campylobacter spp., non-typhoidal Salmonella, and Staphylococcus aureus.

  • Study co-author Ramanan Laxminarayan says they found there was a triple increase in antibiotic resistance risk in food animals from 2000–2018, particularly in low or middle-income countries like India, China and Brazil.
  • Many of these countries have just recently started monitoring and raising awareness of the problem, but farmers tend to overprescribe antibiotics to promote animal growth, causing AMR.
  • "Do we really want to enable [the] factory farming of animals at the cost of animal and human health?" Laxminarayan asks.

The bottom line: Other experts in the field tell Axios they agree there's an urgent need to focus on the AMR Challenge's "one health" approach to target humans, animals and the environment.

  • Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, tells Axios there are two main arms to combating AMR: preventing AMR from developing via good stewardship of current antibiotics and other methods, and "developing a robust pipeline of new antibiotics."
  • Greg Frank, director of the advocacy coalition Working to Fight AMR, agrees, adding that it's important for President Trump and Congress to "lead this fight — by incentivizing the development of new, lifesaving antibiotics" before more drug companies go out of business.
  • Laxminarayan, who also sits on the U.S. Presidential Advisory Council on Combating Antibiotic Resistant Bacteria, says "if you're going to solve this, it has to be [through the] one health issue — for humans and animals together."

Go deeper:

Go deeper

Updated 6 hours ago - Sports

Olympics dashboard

🚨: Japan's Naomi Osaka lights Olympic cauldron; Photos

👻: How the no-spectator Olympics could affect the athletes

🇺🇸: "What an honor it is to watch you soar," first lady tells U.S. Olympians

🌏: Meet the underdogs from Latin America

🥇: The six new sports at Tokyo 2020

💉 About 100 U.S. Olympic athletes are unvaccinated

✍️ Axios at the Olympics: What it's like inside the opening ceremony

Go deeper: Full Axios coverage

Senate Democrats demand answers on FBI's Kavanaugh probe

Photographer: Andrew Harrer/Bloomberg via Getty Images

Senate Democrats are demanding that the FBI hand over "all records and communications" related to the FBI tip line set up to investigate Supreme Court Justice Brett Kavanaugh when he was a nominee in 2018.

Why it matters: The ask comes after the FBI revealed it received more than 4,500 tips about Kavanaugh when he was awaiting Senate confirmation amid sexual assault allegations. Only the most "relevant" of these tips were forwarded to the Trump White House.

Chip relief on the horizon

Illustration: Sarah Grillo

Good news: The worst of the chip supply crunch might be near.

The other side: Here's the bad news... CEOs say chips totally flowing like normal is still a ways out.